Your browser doesn't support javascript.
Insulintherapie ­ neue Insulinanaloga. / [Insulin therapy-new insulin analogues].
Internist (Berl) ; 60(9): 887-894, 2019 Sep.
Artigo em Alemão | MEDLINE | ID: mdl-31396651
A multitude of short-acting and long-acting insulin analogues are currently available for the treatment of diabetes mellitus, which mimic physiological insulin secretion better than normal insulins. By the use of ultrarapid insulin analogues postprandial glucose increases can be significantly reduced. Newer long-acting insulin analogues have a very stable action profile and reduce the rate of hypoglycemia, especially nocturnal hypoglycemia, even more than first generation long-acting insulin analogues. Future developments focus on a further acceleration of prandial insulin effects with a simultaneous shorter effect time and an even more prolonged action of long-acting insulin analogues.





Texto completo: Disponível Coleções: Bases de dados internacionais Base de dados: MEDLINE Assunto principal: Diabetes Mellitus Tipo 2 / Medicamentos Biossimilares / Glucose / Insulina Aspecto clínico: Terapia Limite: Humanos Idioma: Alemão Revista: Internist (Berl) Ano de publicação: 2019 Tipo de documento: Artigo